Search | IOVS | ARVO Journals

Showing 1 – 20 of 113

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina July 2024

Prediction of Long-Term Treatment Outcomes for Diabetic Macular Edema Using a Generative Adversarial Network

PDF

Jiwon Baek; Ye He; Mehdi Emamverdi; Alireza Mahmoudi; Muneeswar Gupta Nittala; Giulia Corradetti; Michael Ip; SriniVas R. Sadda
TAGS: diabetic macular edema, long-term treatment, eye, sensitivity and specificity, anti-vascular endothelial growth factor therapy
Trans. Vis. Sci. Tech.. 2024; 13(7):4. https://doi.org/10.1167/tvst.13.7.4

ARVO Annual Meeting Abstract June 2024

Early real-world fluid-free treatment interval extension following switch to faricimab in the treatment of neovascular age-related macular degeneration with a treat and extend regimen - the first 9 months

Anna Urrea; Charles Patrick O'Neill; Gihan Samarasinghe; Stephanie Mauger; Giang Do; Sophiana Maya Michele Lindenberg; Ayesha Nuri Karamat; Giulia Corradetti; Muneeswar Gupta Nittala; Devinder Chauhan; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4384.

ARVO Annual Meeting Abstract June 2024

Prediction of progression of diabetic retinopathy using automated lesion detection of retinal hemorrhages

Aditya Verma; Muneeswar Gupta Nittala; Marius Facktor; Chaithanya Ramachandra; Malavika Bhaskaranand; Sandeep Bhat; Kaushal Solanki; Chaitra jayadev; Swetha B. Velaga; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3193.

ARVO Annual Meeting Abstract June 2024

Association between visual outcomes and macular fluid subtypes at initiation of anti-VEGF treatment for neovascular age-related macular degeneration - a real-world study

Kathryn Stucker; Giang Do; Charles Patrick O'Neill; Stephanie Mauger; Gihan Samarasinghe; Anna Urrea; Giulia Corradetti; Devinder Chauhan; Sophiana Maya Michele Lindenberg; Ayesha Nuri Karamat; Muneeswar Gupta Nittala; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4358.

ARVO Annual Meeting Abstract June 2024

Evaluating Fingerprint-Like Patterns in the Healthy Henle Fiber Layer Using Enface OCT Imaging

Abbas Habibi; maryam ashrafkhorasani; Mehdi Emamverdi; Ahmad Santina; Giulia Corradetti; Muneeswar Gupta Nittala; K Bailey Freund; David Sarraf; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5910.

ARVO Annual Meeting Abstract June 2024

OCT Angiography Features as Predictors of Anti-VEGF Treatment Response in Diabetic Macular Edema: KINGFISHER study

Mengyuan Fang; Ye He; Muneeswar Gupta Nittala; Shin Kadomoto; Michael S Ip; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4882.

ARVO Annual Meeting Abstract June 2024

Prediction of Long-term Anatomic Treatment Outcomes for Diabetic Macular Edema using a Generative Adversarial Network

Jiwon Baek; Ye He; Mehdi Emamverdi; Alireza Mahmoudi; Muneeswar Gupta Nittala; Giulia Corradetti; Michael S Ip; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2834.

ARVO Annual Meeting Abstract June 2024

Relation between spatial location and lesion growth rate in multifocal geographic atrophy secondary to non-neovascular age-related macular degeneration

Muneeswar Gupta Nittala; Amir Hariri; Swetha Bindu Velaga; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2286.

ARVO Annual Meeting Abstract June 2024

Accuracy of Automated Subretinal Fluid Volume Quantification Using the Macuject Algorithm

Swetha Bindu Velaga; Muneeswar Gupta Nittala; Gihan Samarasinghe; Devinder Chauhan; Charles Clifton Wykoff; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2276.

ARVO Annual Meeting Abstract June 2024

Multivariate Genome-wide Association Study of OCT-derived biomarkers for AMD in the Amish Eye Study

Yeunjoo E. Song; Jessica Cooke Bailey; Farid Rajabli; Muneeswar Gupta Nittala; Renee A Laux; Kristy Miskimen; Daniel A Dorfsman; SriniVas R Sadda; Dwight Stambolian; Margaret A Pericak-Vance; William K Scott; Jonathan L Haines

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4241.

ARVO Annual Meeting Abstract June 2024

Resistance to AMD pathology after age 75 is suggestively linked and associated with a region on chromosome 2q12.2 in the Amish Eye Study

William K Scott; Farid Rajabli; Jessica Cooke Bailey; Daniel A Dorfsman; Yeunjoo E. Song; Muneeswar Gupta Nittala; SriniVas R Sadda; Dwight E Stambolian; Jonathan L Haines; Margaret A Pericak-Vance

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4230.

ARVO Annual Meeting Abstract June 2023

Measuring real-world visual acuity outcomes for ranibizumab and aflibercept in treatment of neovascular age-related macular degeneration (nAMD)

Ayesha Nuri Karamat; Charles O'Neill*; Giulia Corradetti; Sophiana Lindenberg; Jasaman Tojjar; Louay Almidani; Giang Do; Stephanie Mauger; Muneeswar Gupta Nittala; Devinder Chauhan; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3726.

ARVO Annual Meeting Abstract June 2023

Impact of High-Risk Features Associated with AMD Progression on Retinal Sensitivity

Houri Esmaeilkhanian; Muneeswar Gupta Nittala; Swetha B Velaga; David G Birch; Dwight Stambolian; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):296.

ARVO Annual Meeting Abstract June 2023

Longitudinal evaluation of the distribution of intraretinal hyper-reflective foci in eyes with intermediate age-related macular degeneration.

Aditya Verma; Giulia Corradetti; Ye He; Muneeswar Gupta Nittala; Marco Nassisi; Swetha B Velaga; Jonathan L Haines; Margaret A Pericak-Vance; Dwight Stambolian; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2174.

ARVO Annual Meeting Abstract June 2023

Factors associated with switching intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents in the treatment of neovascular age-related macular degeneration (nAMD)

Stephanie Mauger; Charles O'Neill*; Giang Do; Sophiana Lindenberg; Ayesha Nuri Karamat; Giulia Corradetti; Jasaman Tojjar; Louay Almidani; Muneeswar Gupta Nittala; Devinder Chauhan; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2194.

ARVO Annual Meeting Abstract June 2023

Visual and treatment interval outcomes after switching anti-VEGF therapy in the treatment of nAMD

Sophiana Lindenberg; Charles O'Neill*; Giulia Corradetti; Giang Do; Stephanie Mauger; Ayesha Nuri Karamat; Jasaman Tojjar; Louay Almidani; Muneeswar Gupta Nittala; Devinder Chauhan; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2183.

ARVO Annual Meeting Abstract June 2023

Optical coherence tomography characteristics of Intraretinal hyperreflective foci associated with diabetic retinopathy and age-related macular degeneration

maryam ashrafkhorasani; abbas habibi; Mehdi Emamverdi; Muneeswar Gupta Nittala; Swetha B Velaga; Charles Clifton Wykoff; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2133.

ARVO Annual Meeting Abstract June 2023

Clinical relevance of the time course of visual improvement following real-world anti-vascular endothelial growth factor (Anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD)

Charles Patrick O'Neill; Giang Do; Sophiana Lindenberg; Ayesha Nuri Karamat; Giulia Corradetti; Jasaman Tojjar; Louay Almidani; Muneeswar Gupta Nittala; Devinder Chauhan; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2184.

ARVO Annual Meeting Abstract June 2023

Reflectivity of the Retinal Pigment Epithelium in Aging and Early Age-Related Macular Degeneration.

abbas habibi; Mehdi Emamverdi; maryam ashrafkhorasani; Muneeswar Gupta Nittala; SriniVas R Sadda

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2143.

ARVO Annual Meeting Abstract June 2023

Genetic and pathologic predictors of progression from early to advanced age-related macular degeneration

William K Scott; Susan H. Slifer; Kyle M. Scott; Stephen G Schwartz; Jaclyn L. Kovach; SriniVas R Sadda; Muneeswar Gupta Nittala; Jonathan L Haines; Margaret A Pericak-Vance

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):488.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Prediction of Long-Term Treatment Outcomes for Diabetic Macular Edema Using a Generative Adversarial Network

Early real-world fluid-free treatment interval extension following switch to faricimab in the treatment of neovascular age-related macular degeneration with a treat and extend regimen - the first 9 months

Prediction of progression of diabetic retinopathy using automated lesion detection of retinal hemorrhages

Association between visual outcomes and macular fluid subtypes at initiation of anti-VEGF treatment for neovascular age-related macular degeneration - a real-world study

Evaluating Fingerprint-Like Patterns in the Healthy Henle Fiber Layer Using Enface OCT Imaging

OCT Angiography Features as Predictors of Anti-VEGF Treatment Response in Diabetic Macular Edema: KINGFISHER study

Prediction of Long-term Anatomic Treatment Outcomes for Diabetic Macular Edema using a Generative Adversarial Network

Relation between spatial location and lesion growth rate in multifocal geographic atrophy secondary to non-neovascular age-related macular degeneration

Accuracy of Automated Subretinal Fluid Volume Quantification Using the Macuject Algorithm

Multivariate Genome-wide Association Study of OCT-derived biomarkers for AMD in the Amish Eye Study

Resistance to AMD pathology after age 75 is suggestively linked and associated with a region on chromosome 2q12.2 in the Amish Eye Study

Measuring real-world visual acuity outcomes for ranibizumab and aflibercept in treatment of neovascular age-related macular degeneration (nAMD)

Impact of High-Risk Features Associated with AMD Progression on Retinal Sensitivity

Longitudinal evaluation of the distribution of intraretinal hyper-reflective foci in eyes with intermediate age-related macular degeneration.

Factors associated with switching intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents in the treatment of neovascular age-related macular degeneration (nAMD)

Visual and treatment interval outcomes after switching anti-VEGF therapy in the treatment of nAMD

Optical coherence tomography characteristics of Intraretinal hyperreflective foci associated with diabetic retinopathy and age-related macular degeneration

Clinical relevance of the time course of visual improvement following real-world anti-vascular endothelial growth factor (Anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD)

Reflectivity of the Retinal Pigment Epithelium in Aging and Early Age-Related Macular Degeneration.

Genetic and pathologic predictors of progression from early to advanced age-related macular degeneration

To View More...

You must be signed into an individual account to use this feature.